Olea Medical

Olea Medical

Type	Société par actions simplifiée
Founded	2008 in Marseille
Founder(s)	Fayçal Djeridane, Benoît Gy, Cyril Di Grandi, Anca Mitulescu
Headquarters	La Ciotat, France
Area served	Worldwide
Products	Medical imaging software
Services	Imaging training, Consulting in teleradiology
Divisions	Healthcare sector
Website	www.olea-medical.com

Olea Medical develops post-processing software for perfusion imaging dedicated to the optimization of medical images and computer aided diagnosis. The main programs developed by Olea Medical are focused on brain tumor and stroke analysis, in both CT and MRI. The company is also working to develop new applications for the diagnosis of other diseases.

The development of the company is based on close collaborations with expert physicians in Neuroimaging from leading institutions worldwide which use the software in clinical routine: Vall d'Hebron University Hosptial (Spain), Iwate Medical University (Japan), Luxemboug University Hospital, University of California Los Angeles; and in research: National Institute of Health, La Pitié-Salpêtrière Hospital (France).

Olea Medical is headquartered in Marseille (France), and has a subsidiary in Boston for its North American operations.

History

Founder generation

Olea Medical was founded on 9 July 2008, after years of collaboration with Prof. Nicoli from La Timone University Hospital (Marseille, France). The first software was dedicated to the visualization and analysis of MR data to help physicians in their diagnosis. The company has seen a rapid growth, working with many medical centers not just in France but worldwide. Its engineers come from the aerospace and defence industries DCNS, thus explaining its know-how in software optimization (fast computation and software architecture).

Growth and approvals

In 2009, the software PerfScape and NeuroScape have beencleared by the U.S> Food and Drug Administration and CE marked, allowing Olea Medical to commercialize its products in the US and European markets. During the same year Olea Medical has enlarged its medical advisory board and new partnerships were established with internationally renowned institutions such as the National Institute of Health. Collaborating with new experts in neuroimaging allowed Olea Medical to extend its expertise and develop new versions of its software, which have been CE marked in 2010.

International development

The company participated in several scientific congresses worldwide such as ESC 2010 in Barcelona and Radiological Society of North America (RSNA) 2011 in Seattle. Olea Medical software are used in 2011 in the United States, Canada, France, Spain, Italy, Switzerland, Luxembourg, Belgium, United Kingdom, Japan and South Korea.

Medical advisory board members

Olea Medical benefits from strong supports of experts in the field of brain imaging through its Medical Advisory Board:

• François Nicoli: President of the Medical Advisory Board; expert in stroke care management; head of the Stroke Center of La Timone University Hospital in Marseille.
• Kenneth Butcher: Expert in cerebral perfusion imaging in acute stroke; member of the Heart & Stroke Association; associate Professor in the division of Neurology, University of Alberta in Edmonton.
• Nadine Girard: Expert in adult and pediatric neuroradiology; director of the Diagnostic and Interventional Neuroradiology department at La Timone University Hospital in Marseille.
• Philippe Grenier: Expert in radiology; president Elect of the ESTI (European Society of Thoracic Imaging); honorary member of the RSNA (Radiological Society of North America); director of the diagnostic, polyvalent and interventional radiology department at La Pitié-Salpêtrière Hospital in Paris.
• Didier Leys: Expert in neurology; president elect of the European Stroke Organisation (ESO); professor of Neurology and Head of the Neurological Department at Lille University Hospital in Lille.
• Thierry Moulin: Expert in neurology; vice-president of the Neurovascular French Society; head of the stroke unit and professor of Neurology at the University Hospital of Besançon.
• Alejandro Rovira Cañellas: Expert in neuroradiology; director of the European Course of Neuroradiology; director of the MR Unit at Vall d'Hebron Hospital.
• Makoto Sasaki: Expert in neuroradiology; professor in the High Field MRI Section at the Advanced Medical Research Center, Iwate Medical University.
• Jean-Paul Soucy: Expert in nuclear medicine; associate Professor of Radiology at McGill University; director of Positron Emission Tomography (PET) Unit, McConnell Brain Imaging Centre at Montreal Neurological Institute and Hospital.
• Lawrence Tanenbaum: Expert in radiology; past-president of the Clinical Magnetic Resonance Imaging Society and Senior member of the American Society of Neuroradiology; associate Professor of Radiology and Director of MRI, CT and Outpatient / Advanced Imaging Development at Mount Sinai School of Medicine in New-York.
• Robert Tarr: Expert in neuroradiology; past-president of the Society of Neurointerventional Surgery (SNIS); professor of Radiology and Neurosurgery at the Case Western Reserve University School of Medicine and head of the Neuroradiology Unit at the University Hospitals Case Medical Center.
• Key Yamada: Expert Neuroradiologist within the Department of Radiology at Kyoto Prefectural University of Medicine.

Products

Olea Medical developed two programs:

PerfScape

PerfScape is a program mainly used to compute perfusion maps (rCBV, rCBF, MTT, TTP, TMax, TMIP) from PWI sequence. It allows the physician to modify several parameters to adjust the maps such as the deconvolution method, AIF selection, motion correction and noise removing. The utilization of this application is very fast regarding to the entire diagnosis workflow: according to Olea Medical, few seconds are necessary with this software to compute perfusion maps.

NeuroScape

This second software has been developed to help doctors in making the diagnosis. The main window is a synchronized and rescaled visualization of all maps, with different tools to measure and analyze the brain lesions. Other innovative features are available depending on the version used: core and penumbra volume estimation for the CT Stroke version; mismatch calculation for MR Stroke version; corrected rCBV and permeability map for MR Brain Tumor version.

See also

• Perfusion imaging
• Stroke
• Brain tumor
• National Institute of Health
• Radiological Society of North America

External links

• Olea Medical website
• Article about Olea Medical on the Econostrum website (French)
• Article about Olea Medical on the Oseo website (French)
• Article about Olea Medical on the Med'in Marseille website (French)